概述
The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.
深入探讨
The Health Data, Technology, and Interoperability (HTI-1) final rule updates ONC’s Health IT Certification Program. One part addresses algorithm transparency for predictive decision support interventions in certified health IT. ONC describes these requirements as providing clinical users with a consistent baseline of information to assess algorithms for fairness, appropriateness, validity, effectiveness, and safety. The rule focuses on certified health IT and defined predictive decision support interventions. It does not create a blanket disclosure requirement for every AI product used in healthcare. Developers must identify whether a function falls within the relevant certification criteria and provide required source attributes. Health systems should understand the certified product scope and use available documentation when evaluating a tool. Transparency supports evaluation, but disclosure alone does not show that a model performs well or is safe. Users still need to consider local population, workflow, data quality, clinical evidence, and ongoing monitoring. The rule became effective in March 2024, and organizations should check current ONC materials for implementation details and corrections. Do not confuse HTI-1 transparency requirements with FDA device authorization or other privacy and safety obligations. Implementation requires understanding whether a decision-support function is offered through certified health IT and which version is in use. A deployment may include multiple algorithms, so one disclosure should not be assumed to describe every feature. Clinicians need information in a form that supports practical review during their workflow.
战略影响
风险与安全
灾难性和日常的人工智能危害都取决于谁了解风险以及谁能够采取行动。
更清晰的判决
公众和专业素养决定强有力的安全政策在政治上是否可行。
打破炒作
清晰的解释可以减少炒作、实验室公关和模糊道德剧场的影响。
The Future of ONC HTI-1 Algorithm Transparency Rule
Algorithm transparency may make it easier for clinicians to inspect baseline information about decision-support tools. It cannot replace independent evaluation, governance, or regulatory review. ONC may issue implementation updates, and certified developers may revise products. Health systems should maintain a process to review disclosures, ask vendors questions, and reassess interventions after changes. Transparent information is most useful when users can access it before relying on a recommendation and have a route to raise concerns. Support user questions promptly and clearly.
现实世界的实施
A certified EHR developer documents source attributes for a predictive decision-support function.
A clinic checks whether an algorithm is within the certified health IT scope before applying HTI-1 requirements.
A clinician reviews available information about a model’s intended use and limitations.
An implementation team maps each predictive intervention to the required transparency criteria.
风险与防护栏
将存在风险视为科幻小说,同时能力复合。
混淆了表面产品安全与高度自治下的对准。
只给非英语和非专业观众留下低质量的资源。
实施路线图
单独的产品危害、误用和失控/失调风险。
询问哪些证据会改变您对时间表和严重性的看法。
比起营销主张,更喜欢主要来源和具体评估。
确定一条行动路径:职业、政策、资金或技能——而不仅仅是意识。
不断探索
Free newsletter
Get the daily AI briefing
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Take the ONC HTI-1 Algorithm Transparency Rule quiz
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
常见问题
What is ONC HTI-1 Algorithm Transparency Rule?
ONC’s HTI-1 final rule updates the Health IT Certification Program and establishes transparency requirements for predictive decision support interventions in certified health IT. The requirements apply within the certification framework, not to every AI tool. Health IT developers disclose defined source attributes so clinical users can assess appropriateness, validity, safety, effectiveness, and fairness.
What can required source attributes help users assess?
ONC describes these evaluation dimensions for clinical users.
Does HTI-1 transparency prove a model is safe?
Disclosure is not a substitute for evidence and local evaluation.
How does HTI-1 relate to FDA authorization?
HTI-1 certification and FDA device rules are distinct frameworks.
继续学习
相关指南
为此主题精选的更多指南